Development of a nomogram for predicting overall survival in patients with primary male breast cancer
Eurasian Journal of Medicine and Oncology · 09.03.2026 · 025380403
DOI: 10.36922/ejmo025380403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 09.03.2026. Verfasst von Fanfan Tang und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Male breast cancer (MBC) is a rare malignancy and, in some cohorts, has been associated with a less favorable prognosis compared to female breast cancer. MBC patients also face an elevated risk of secondary cancers, complicating the identification of disease-specific prognostic factors. Moreover, research focusing exclusively on primary MBC without prior or concurrent malignancies remains limited, hindering accurate outcome prediction for this population.
Objective
This study aims to identify independent prognostic factors and develop a predictive nomogram for MBC.
Methods
Using data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results program, we analyzed clinicopathological characteristics and survival outcomes in MBC patients. Variable selection was performed using the least absolute shrinkage and selection operator regression, and multivariable Cox regression was applied to evaluate the impact of factors, including age, tumor grade, tumor size, lymph node status, estrogen receptor/progesterone receptor status, and human epidermal growth factor receptor 2 expression, on overall survival. Calibration curves were generated to assess the predictive accuracy of the nomogram for three‑, five‑, and 10‑year survival.
Results
Multivariable Cox regression analysis showed that age, marital status, surgery, tumor size, pathological grade, TNM stage, brain metastasis, and chemotherapy were independent factors affecting the survival prognosis of MBC patients. The nomogram showed good predictive performance (C-index = 0.763, 95% confidence interval: 0.57–0.94), and the calibration curve showed high agreement between the model’s predicted 3-year survival and actual survival. However, predictions for 5- and 10-year survival were unstable.
Conclusion
This study identified age, marital status, surgery, tumor size, pathological grade, TNM stage, brain metastasis, and chemotherapy as significant predictors of overall survival in MBC. A nomogram incorporating these variables showed reliable performance for short-term survival prediction. Early diagnosis and treatment are pivotal in improving the survival rate of MBC.
Zitieren
APA
Tang, F., Zhu, L., Wang, W., Zhao, Y., & Hu, Y. (2026). Development of a nomogram for predicting overall survival in patients with primary male breast cancer. Eurasian Journal of Medicine and Oncology, 0(0), 025380403. https://doi.org/10.36922/ejmo025380403
Vancouver
Tang F, Zhu L, Wang W, Zhao Y, Hu Y. Development of a nomogram for predicting overall survival in patients with primary male breast cancer. Eurasian Journal of Medicine and Oncology. 2026;0(0):025380403. doi:10.36922/ejmo025380403
BibTeX
@article{Tang2026,
author = {Tang, Fanfan and Zhu, Lei and Wang, Wanju and Zhao, Yanyan and Hu, Yina},
title = {Development of a nomogram for predicting overall survival in patients with primary male breast cancer},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {025380403},
doi = {10.36922/ejmo025380403}
}
EUVIMED